Improvements in Photonic Imaging is Changing Healthcare Landscape

Improvements in Photonic Imaging is Changing Healthcare Landscape

PR Newswire

LOS ANGELES, March 19, 2018 /PRNewswire/ —

FN Media Group Presents USA News Group News Commentary 

Nuclear imaging, while not new, is quickly proliferating into new arenas of health diagnosis while also increasing in capability in existing areas of application leading to a major shift in the healthcare landscape.

Companies directly tied to the impact of Photonics and Imaging include ASML Holding N.V. (NASDAQ: ASML), Coherent, Inc. (NASDAQ: COHR), IPG Photonics Corporation (NASDAQ: IPGP) and Zecotek Photonics Inc. (OTC: ZMSPF) (TSX.V: ZMS).

The technology that goes into telling doctors what is going on inside their patient’s bodies is a critical element of modern day medicine. Medical imaging techniques such as X-rays, MRI, and CT scanning all transformed the health industry to a great extent when they were developed. Now, new approaches to imaging technologies are transforming the capabilities once again.

Several companies are heavily involved and contribute to the changes taking place. Others who deal directly with the imaging technologies include ASML Holding N.V. (NASDAQ: ASML), Coherent, Inc. (NASDAQ: COHR), and IPG Photonics Corporation (NASDAQ: IPGP).

One small, yet significant contributor in this space is Canadian innovator Zecotek Photonics Inc. (OTC: ZMSPF) (TSX.V: ZMS), a junior photonics tech firm, with over 50 patents and patent-pending technologies.

Big breakthroughs are happening across the entire photonics sector, and within the surge the sector has created and sustained several multi-billion-dollar companies, along with major opportunities for newcomers like Zecotek.


From minute problems like joint dislocations to the terrifying scourge that is cancer, internal imaging has improved diagnosis accuracy and pooled knowledge of disease progression. Being non-invasive, painless and quick, these imaging techniques help to detect disease at early stages of development and aid in reducing recovery time and mortality.

While current technologies have an amazing record of improving healthcare, they do have their shortcomings and continuous improvements are needed. The technology continues to improve through the incorporation of new techniques such as 3D and 4D technologies that can produce more advanced images.

Doctors are also able to share imaging information through cloud-based platforms by uploading digital images through networked arrays.

Nuclear imaging technology has been used for quite a while for cancer and heart diseases and is now increasingly being used for neurological disorders.

Through the use of PET, FDG and SPECT imaging, clinicians are able to make early diagnosis of neurodegenerative disorders such as dementia.

In recent years, many hospitals around the world have unrolled a technique known as amyloid PET imaging which detects abnormal protein deposits that are associated with Alzheimer’s disease. The technology provides more detailed imaging than more conventional radiotracers.

Researchers are also working on more advanced PET imaging techniques including inflammation imaging and tau imaging.


There are many notable improvements happening in the field of nuclear imaging. One of the most important advancements involves merging the benefits of PET and CT imaging.

PET/CT conflated systems have been in the market since 2001 and have significantly improved image resolutions. PET/CT combines anatomical and functional information acquired from the two configurations. Physicians get more accurate information which makes diagnosis more accurate.

Rather than taking separate images, this framework simultaneously scans the body in the same position for both PET and CT modalities. The patient’s scan time is significantly reduced because they do not have to undergo separate examinations.

This is a major milestone in imaging.


Another area gaining a footing is Photonics. Whereas “Electronics relies on the movement of the Electron, “Photonics relies on the movement of the Photon which travels at the speed of light.”

Fiber Optics, Lasers, quantum computing, Imaging, Data Storage, Data transfer, Data visualization such as 3D, Terahertz wireless communication, to name a few, are fast growing technologies enabled by the science of Photonics, shaping almost every major industry and creating new ones.

For example, junior developer Zecotek Photonics is forwarding several new photonics based innovations.

Zecotek’s LFS scintillation crystals and MAPD Silicon Photo-Multipliers are being used inside the equipment of major world-changing research, including the world’s first total body PET scanner, and Neurological PET scanner, and IHEP (World Largest Particle Accelerator Program) as well as CERN’s CMS experiment that aids in finding dark matter, other dimensions, and possibly better understanding of the mechanisms of the origins of existence itself.

While the high-profile uses of Zecotek’s LFS crystals are involved in some of the world’s most major research breakthroughs, it’s with the photonics developer’s other technologies that you’ll be more likely to encounter in your day-to-day lives.

Zecotek is at the vanguard of a new generation of glasses-free 3D displays-with a patented data processing module that provides for real-time capability, with a system capable of transferring data for up to ninety views in full high definition.

The company is also developing a compact, high-speed 3D printer, which will use high-performance metal alloys and offers technical and commercial advantages over competing technologies.


In order to improve image quality, scientists have been relying on tweaks in bed motion and continuous data acquisition. Industry heavy hitters such as Siemens Healthcare, Phillips Health Care and GE Healthcare all have novel PET/CT systems that have already received FDA approval.

Siemen’s Biograph mCT Flow PET/CT uses a technology branded as “FlowMotion”, which moves the patient continuously through the system’s gantry, yield stronger data streams than previous stop-and-go configurations.

The Vereos PET/CT from Philips replaced the traditional analog detectors with digital silicon photomultiplier detectors, which reportedly doubled the sensitivity gain, volumetric resolution and quantitative accuracy.

General Electric’s Q.Clear PET/CT technology reportedly delivers two times improvements in image quality and quantitative accuracy. Industry experts believe that FlowMotion, SPECT/CT imaging will be important trends to watch in the near future.

Unlike many research fields, Photonics appears to also be a lucrative end of the business.

Out of a recent sample group of the photonics majors, each company that made major technological breakthroughs in the field experienced massive gains as they surpassed billion-dollar market caps.

Clearly there’s great opportunity in the new era of medical imaging and true innovators in the space could end up being the hot spot for early backers.



ASML is one of the world`s leading manufacturers of chip-making equipment. Our vision is to enable affordable microelectronics that improve the quality of life. To achieve this, our mission is to invent, develop, manufacture and service advanced technology for high-tech lithography, metrology and software solutions for the semiconductor industry.

Coherent, Inc. (NASDAQ: COHR) 

Coherent, Inc. provides lasers and laser-based technology in a range of scientific, commercial, and industrial applications worldwide. It operates through two segments, Specialty Lasers and Systems, and Commercial Lasers and Components. The company designs, manufactures, services, and markets lasers, laser tools, precision optics, and related accessories. Its products are used in markets, such as microelectronics, materials processing, original equipment manufacturer components and instrumentation, and scientific research and government programs.

IPG Photonics Corporation (NASDAQ: IPGP) 

IPG Photonics Corporation is the world leader in high-power fiber lasers and amplifiers. Founded in 1990, IPG pioneered the development and commercialization of optical fiber-based lasers for use in diverse applications, primarily materials processing. Fiber lasers have revolutionized the industry by delivering superior performance, reliability and usability at a lower total cost of ownership compared with conventional lasers, allowing end users to increase productivity and decrease operating costs. IPG has its headquarters in Oxford, Massachusetts, and has additional plants and offices throughout the world.

For a more in-depth look into ZMS you can view the in-depth report at USA News Group:

Article Source:
USA News Group 

Legal Disclaimer/Disclosure This piece is an advertorial and has been paid for. This document is not and should not be construed as an offer to sell or the solicitation of an offer to purchase or subscribe for any investment. No information in this Report should be construed as individualized investment advice. A licensed financial advisor should be consulted prior to making any investment decision. We make no guarantee, representation or warranty and accept no responsibility or liability as to its accuracy or completeness. Expressions of opinion are those of USA News Group only and are subject to change without notice. USA News Group assumes no warranty, liability or guarantee for the current relevance, correctness or completeness of any information provided within this Report and will not be held liable for the consequence of reliance upon any opinion or statement contained herein or any omission. Furthermore, we assume no liability for any direct or indirect loss or damage or, in particular, for lost profit, which you may incur as a result of the use and existence of the information, provided within this Report.

DISCLAIMER: USA News Group is Source of all content listed above. FN Media Group, LLC (FNM), is a third party publisher and news dissemination service provider, which disseminates electronic information through multiple online media channels. FNM is NOT affiliated in any manner with USA News Group or any company mentioned herein. The commentary, views and opinions expressed in this release by USA News Group are solely those of USA News Group and are not shared by and do not reflect in any manner the views or opinions of FNM. FNM is not liable for any investment decisions by its readers or subscribers. FNM and its affiliated companies are a news dissemination and financial marketing solutions provider and are NOT a registered broker/dealer/analyst/adviser, holds no investment licenses and may NOT sell, offer to sell or offer to buy any security. FNM was not compensated by any public company mentioned herein to disseminate this press release.


This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected,” “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and FNM undertakes no obligation to update such statements.

Media Contact Information:
FN Media Group, LLC
U.S. Phone: +1-(954)-345-0611


Legal Cannabis Sales set to Grow as California Projected to Have an Impact

Legal Cannabis Sales set to Grow as California Projected to Have an Impact News Commentary

PR Newswire

NEW YORK, March 19, 2018 /PRNewswire/ —

According to a research by Ameri Research Inc., the global legal cannabis market was valued at $14.3 billion in 2016 and is estimated to grow at a CAGR of 21.1% between 2017 to 2024 by reaching a value of $63.5 billion by 2024. The market is going through a period of robust growth because of increasing legalization and decriminalization of cannabis products across North America. The state of California has legalized products for recreational use on January 1st. The state is expected to play a significant role in the development of the industry. The new industry is also expected to contribute to California’s tax revenue. The LA times reported that, California is on the verge of creating a legal market for cannabis worth more than $5 billion that will help make the state a destination for pot-loving tourists. FinCanna Capital Corp. (OTC: FNNZF), Zynerba Pharmaceuticals, Inc. (NASDAQ: ZYNE), General Cannabis Corp (OTC: CANN), Vitality Biopharma, Inc. (OTC: VBIO), Emerald Health Therapeutics, Inc. (OTC: EMHTF)

Last week Forbes has reported that a bipartisan pair of California lawmakers have announced a bill which would drop the state excise tax on cannabis to from 15% to 11% for a period of three years. Beau Whitney, a senior economist at data analytics for New Frontier Data, which conducted an analysis of the bill, explained to Leafly that, “by lowering the excise tax and postponing the cultivation tax, it will lower the overall price for consumers at the register, which will also reduce the differential between illicit and legal prices… Reducing this gap is critical to making the legal market more competitive against the illicit market and more attractive for consumers.”

FinCanna Capital Corp. (OTC: FNNZF) also listed on the Canadian Securities Exchange under the trading symbol (CSE: CALI). Just earlier today the company announced breaking news that, “”it has received its listing on the OTCQB under the symbol “FNNZF” and provides the following update on the interim medical cannabis extraction facility (“Extraction Facility”) of Cultivation Technologies Inc. (“CTI”), FinCanna’s first investment in California. As announced on January 15, 2018, CTI took over direct operations of its Extraction Facility operating at its site in Coachella, California and CTI has the rights to 100% of the production capacity. CTI is quickly advancing towards commercialization and ramping revenue at the Extraction Facility from which FinCanna is entitled to receive 50% of the profits.

This Extraction Facility can currently process an estimated 6,000 pounds of biomass per month translating to approximately 3.7 million grams of raw oil per year. CTI has the ability to add an additional extraction machine and fractional distillation and winterization equipment. This would result in additional capacity to process 3,000 pounds of biomass per month and the ability to service third-party vaporizer, winterization and distillation customers at a scale of approximately 100,000 grams of finished product weekly.

CTI’s Coachella Premium Brand – CTI’s own brand, Coachella Premium, recently introduced a line of medical concentrates which are now available for sale to all California licensed dispensaries. CTI is currently expanding its product line to include vaporizer cartridges, which will become available in the coming weeks. Initial market feedback gathered during the product development phase indicates that Coachella Premium’s vaporizer cartridges offer a unique proposition within the vaporizer market, one of the fastest growing verticals in the cannabis market.

Manufacturing and Distribution Services – Since taking operational control at its Extraction Facility, and after obtaining state temporary licenses, CTI has acquired key accounts for contracted manufacturing and distribution. Private label services have commenced at the site, providing brands which otherwise had no legal avenue to participate in the licensed environment, a legal solution to maintain their presence in the market.

Implementation of Commercial Sales Team – To commercially advance these opportunities, CTI has hired an experienced sales team consisting of a director of sales, two full-time sales managers, and three independent sales contractors. Chip Coble, the Company’s new director of sales, joined the CTI team in the beginning of March and brings with him over 25 years of channel sales and operations management, overseeing teams as big as 100 and managing multi-million-dollar budgets. He will be overseeing the sales of CTI’s exclusive line of branded cannabis products: Coachella Premium TM, as well as direct B2B sales under CTI’s manufacturing and distribution operations. CTI’s sales organization is strategically set up to serve designated zones throughout California to ensure statewide market penetration.

Industry Developments – The state of California is taking steps to curtail the operations of the black market. Regulators have begun sending cease and desist letters to unlicensed operators, including advertising companies which have continued to support unlicensed operators. In addition, an effort to support the businesses which have invested time and capital to reach legal status has begun with the introduction of amendments to Assembly Bill (3157). The amendments propose to reduce the price disparity between legal cannabis business and black-market sources by suspending the state’s cultivation tax and reducing the state’s excise tax until 2021. These efforts highlight the state’s support for compliant business, strengthening the value proposition and opportunity in front of compliant operators such as CTI. With the passing of Proposition 64 in November 2016 and legalization of adult use taking effect January 1, 2018, the state of California is now the world’s largest regulated cannabis market and estimated to be worth $6.45 billion by 2020. More information on the effects of the changing landscape in California can be found here.

About Cultivation Technologies – Cultivation Technologies, Inc. provides infrastructure, technology, and branding to the licensed medical cannabis industry. The first major project for the company is in Coachella, California, which will span 6- acres featuring cultivation centers, extraction and manufacturing facilities, a testing lab, a distribution hub, and a centralized processing center. For more information, visit”

Zynerba Pharmaceuticals, Inc. (NASDAQ: ZYNE) is a clinical-stage specialty pharmaceutical company dedicated to developing and commercializing innovative pharmaceutically-produced transdermal cannabinoid treatments for rare or near-rare neuropsychiatric diseases with high unmet medical needs. On March 5, 2018, the company announced the results of a positive meeting held with the U.S. Food and Drug Administration (FDA) regarding its planned development strategy for ZYN002 in Fragile X syndrome (FXS). FXS is a rare genetic developmental disability that is the leading known cause of both inherited intellectual disability and autism spectrum disorder. ZYN002 is the first and only pharmaceutically-produced cannabidiol (CBD) formulated as a patent-protected permeation-enhanced transdermal gel. Zynerba has received U.S. Orphan Drug designation for the use of CBD as a treatment of FXS. Currently, there are no approved therapies to treat FXS or its most common symptoms.

General Cannabis Corp (OTCQB: CANN) is the comprehensive national resource for the highest quality service providers available to the regulated cannabis industry. On February 2, 2018, the company announced that its client, Green Leaf Medical LLC, a leading grower and supplier of medical cannabis in Maryland, has successfully harvested its first crop and has passed all state-required laboratory tests. Now producing an estimated 500-600 pounds of high-quality medical marijuana on a monthly basis, Green Leaf is one of the leading fully approved suppliers in Maryland. Green Leaf also announced that it has begun the next phase of its expansion, increasing the size of its facility to approximately 50,000 square feet, a 67 percent increase from current capacity. The expanded grow house should be completed before the end of the year, raising production totals to nearly 1,000 pounds per month.

Vitality Biopharma, Inc. (OTCQB: VBIO) is dedicated to unlocking the power of cannabinoids for the treatment of serious neurological and inflammatory disorders. On January 17, 2018, the company announced it has submitted an orphan drug designation request for VITA-100 to the U.S. Food & Drug Administration. Vitality Biopharma’s gut-targeted cannabosides enable delivery of THC without psychoactivity or intoxication, which may enable more widespread use of cannabinoids for treatment of pediatric digestive disorders. The Company has already completed studies that demonstrate the efficacy of cannabosides for treatment of preclinical models of colitis. Cannabosides were able to reduce weight loss, decrease damage to the colon, and markedly improve gastrointestinal health compared to the placebo controls.

Emerald Health Therapeutics, Inc. (OTCQX: EMHTF) operates through Emerald Health Therapeutics Canada Inc. (“EHTC”), a wholly owned subsidiary and Licensed Producer under Canada’s Access to Cannabis for Medical Purposes Regulations. Through EHTC, Emerald is authorized to produce and sell dried cannabis and cannabis oil for medical purposes. It operates an indoor facility in Victoria, BC, and is building a 500,000 ft2greenhouse on 32 acres in Metro Vancouver, with expansion potential to 1 million ft2 to serve the anticipated legal Canadian adult-use cannabis market starting in 2018. Recently, the company and Village Farms International, Inc. announced that Health Canada has issued a Cultivation Licence for their co-owned Delta 3 greenhouse operation under Canada’s Access to Cannabis for Medical Purposes Regulations (“ACMPR”). This optimally-designed 1.1 million ft2 cannabis growing facility is located in one of the best growing climates in Canada in Delta, BC, and is conservatively projected to produce 75,000 kg of quality cannabis annually at full production.

Subscribe Now! Watch us report LIVE

Follow us on Twitter for real time Financial News Updates:

Follow and talk to us on Instagram:

Facebook Like Us to receive live feeds:

About, a leading financial news informational web portal designed to provide the latest trends in Market News, Investing News, Personal Finance, Politics, Entertainment, in-depth broadcasts on Stock News, Market Analysis and Company Interviews. A pioneer in the financially driven digital space, video production and integration of social media, creates 100% unique original content. also provides financial news PR dissemination, branding, marketing and advertising for third parties for corporate news and original content through our unique media platform that includes Newswire Delivery, Digital Advertising, Social Media Relations, Video Production, Broadcasting, and Financial Publications.

Please Note: is not a financial advisory or advisor, investment advisor or broker-dealer and do not undertake any activities that would require such registration. The information provided on (the ‘Site’) is either original financial news or paid advertisements provided [exclusively] by our affiliates (sponsored content),, a financial news media and marketing firm enters into media buys or service agreements with the companies which are the subject to the articles posted on the Site or other editorials for advertising such companies. We are not an independent news media provider and therefore do not represent or warrant that the information posted on the Site is accurate, unbiased or complete. receives fees for producing and presenting high quality and sophisticated content on along with other financial news PR media services. does not offer any personal opinions, recommendations or bias commentary as we purely incorporate public market information along with financial and corporate news. only aggregates or regurgitates financial or corporate news through our unique financial newswire and media platform. For fincanna capital corp. financial news dissemination and PR services, has been compensated five thousand dollars by the company fincanna capital corp. Our fees may be either a flat cash sum or negotiated number of securities of the companies featured on this editorial or site, or a combination thereof. The securities are commonly paid in segments, of which a portion is received upon engagement and the balance is paid on or near the conclusion of the engagement. will always disclose any compensation in securities or cash payments for financial news PR advertising. does not undertake to update any of the information on the editorial or Site or continue to post information about any companies the information contained herein is not intended to be used as the basis for investment decisions and should not be considered as investment advice or a recommendation. The information contained herein is not an offer or solicitation to buy, hold or sell any security., members and affiliates are not responsible for any gains or losses that result from the opinions expressed on this editorial or Site, company profiles, quotations or in other materials or presentations that it publishes electronically or in print. Investors accept full responsibility for any and all of their investment decisions based on their own independent research and evaluation of their own investment goals, risk tolerance, and financial condition. By accessing this editorial and website and any pages thereof, you agree to be bound by the Terms of Use and Privacy Policy, as may be amended from time to time. None of the content issued by constitutes a recommendation for any investor to purchase, hold or sell any particular security, pursue a particular investment strategy or that any security is suitable for any investor. This publication is provided by Each investor is solely responsible for determining whether a particular security or investment strategy is suitable based on their objectives, other securities holdings, financial situation needs, and tax status. You agree to consult with your investment advisor, tax and legal consultant before making any investment decisions. We make no representations as to the completeness, accuracy or timeless of the material provided. All materials are subject to change without notice. Information is obtained from sources believed to be reliable, but its accuracy and completeness are not guaranteed. For our full disclaimer, disclosure and Terms of Use, please visit: .

Media Contact:



Thinking about buying stock in Apple, Facebook, Universal Display Corporation, Tesla Motors or Twitter?

Thinking about buying stock in Apple, Facebook, Universal Display Corporation, Tesla Motors or Twitter?

PR Newswire

CHICAGO, March 19, 2018 /PRNewswire/ – InvestorsObserver issues critical PriceWatch Alerts for AAPL, FB, OLED, TSLA, and TWTR.

Click a link below then choose between a stock score report or an in-depth options trade idea report.

Options Report – Ideal trade ideas on up to seven different options trading strategies. The report shows all vital aspects of each option trade idea for each stock.

Stock Report - Measures a stock’s suitability for investment with a proprietary scoring system combining short and long-term technical factors with Wall Street’s opinion including a 12-month price forecast.

(Note: You may have to copy this link into your browser then press the [ENTER] key.)


Cision View original content:

SOURCE InvestorsObserver